Key result
Acute pretreatment with pravastatin and simvastatin significantly reduced infarct size to 10% and 27% respectively, compared to 42% in untreated control rat hearts subjected to ischemia/reperfusion.
Why the study?
Does acute pretreatment with simvastatin or pravastatin reduce myocardial stunning, arrhythmias, and lethal injury in isolated rat hearts subjected to ischemia/reperfusion?
Does acute pretreatment with simvastatin or pravastatin reduce myocardial stunning, arrhythmias, and lethal injury in isolated rat hearts subjected to ischemia/reperfusion?
Differences in water solubility of statins may underlie their distinct cardioprotective effects on myocardial stunning and lethal injury induced by ischemia/reperfusion.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; hypothesis-generating for acute statin cardioprotection in ischemia/reperfusion.
Although both lipophilic and more hydrophilic statins share the same pathway of the inhibition of HMG-CoA reductase, their pleiotropic cardioprotective effects associated with the ability to cross cellular membranes, including membranes of heart cells, may differ. To test this hypothesis, isolated rat hearts were Langendorff-perfused either with simvastatin (S, 10 micromol/l) or pravastatin (P, 30 micromol/l), 15 min prior to ischemia. Control untreated hearts (C) were perfused with perfusion medium only. Postischemic contractile dysfunction, reperfusion-induced ventricular arrhythmias and infarct size were investigated after exposure of the hearts to 30-min global ischemia and 2-h reperfusion. Both lipophilic S and hydrophilic P reduced the severity of ventricular arrhythmias (arrhythmia score) from 4.3 +/- 0.2 in C to 3.0 +/- 0 and 2.7 +/- 0.2 in S and P, respectively, (both P < 0.05), decreased the duration of ventricular tachycardia and suppressed ventricular fibrillation. Likewise, the extent of lethal injury (infarct size) determined by tetrazolium staining and expressed in percentage of risk area, was significantly lower in both treated groups, moreover, the effect of P was more pronounced (27 +/- 2 % and 10 +/- 2 % in S and P groups, respectively, vs. 42 +/- 1 % in C; P < 0.05). In contrast, only S, but not P, was able to improve postischemic recovery of left ventricular developed pressure (LVDP; 48 +/- 12 % of preischemic values vs. 25 +/- 4 % in C and 21 +/ -7 % in P groups; P < 0.05). Our results suggest that differences in water solubility of statins indicating a different ability to cross cardiac membranes may underlie their distinct cardioprotective effects on myocardial stunning and lethal injury induced by ischemia/reperfusion.
No takes yet. Share an insight, caveat, or question.
Čarnická et al. (2011) studied Myocardial ischemia/reperfusion injury (n=36). Simvastatin and Pravastatin vs. Perfusion medium only (Control) was evaluated on Infarct size (percentage of left ventricular area) (p=<0.05). Acute pretreatment with pravastatin and simvastatin significantly reduced infarct size to 10% and 27% respectively, compared to 42% in untreated control rat hearts subjected to ischemia/reperfusion.
Synapse has enriched 10 related papers. Consider them for comparative context: